
Off-target toxicity is one of the leading causes of clinical failure, making cell health and proliferation assays essential for compound screening, toxicology, and therapeutic development. Confidently advance your best candidates with one knowledgeable partner who you can trust to design and run the right assay to support your next decision point.
By partnering with Concept Life Sciences, you will benefit from:
Exclude unfit compounds quickly and advance your best candidates with confidence, with our streamlined processes for faster turnaround. All this under one-roof!
Having vast experience in tailored development of in vitro assays, we provide competitive, pre-optimized, ready-to-use solutions, supporting your progression to the clinic. Our integrated approach ensures faster turnaround, reduced risk, and seamless alignment with related in vitro assays such as pathway engagement and ADMET assessments for confident decision making.
Cell painting is a high-content imaging technique that captures detailed morphological “fingerprints” of cellular health and behavior. This powerful approach helps:

While U2OS cells are commonly used in cell painting assays, our expertise goes far beyond. We have hands-on experience imaging a wide range of cell types—including immortalized cell lines, iPSC-derived cells, and primary cells. Leveraging our deep knowledge in culturing and imaging diverse cellular models, we offer tailored support to help drive the success of your phenotypic screening projects.
Leverage the Incucyte® live-cell imaging system for real-time, non-invasive monitoring of cell proliferation, death, and immune response. Designed for high-throughput analysis, this platform provides precise kinetic data to accelerate decision-making and reveal deep biological insights across diverse therapeutic areas.
Our fit-for-purpose, pre-optimized assays are ready to use or fully customizable:
A: In vitro assays that measure cell viability, toxicity, and growth to evaluate compound effects during drug discovery.
A: They identify off-target toxicity early, preventing costly failures in preclinical and clinical stages.
A: Tools such as Incucyte® imaging and cell painting allow real-time, high-content analysis of cellular responses.
A: Yes. Concept Life Sciences designs tailored assays using the most relevant cell models and detection platforms for your project.